N-terminal prohormone brain natriuretic peptide as a predictor of cardiovascular disease and mortality in blacks with hypertensive kidney disease - The African American Study of Kidney Disease and Hypertension (AASK)

被引:37
|
作者
Astor, B. C. [1 ,2 ]
Yi, S. [1 ]
Hiremath, L. [3 ]
Corbin, T. [4 ]
Pogue, V. [5 ]
Wilkening, B. [6 ]
Peterson, G. [7 ]
Lewis, J. [8 ]
Lash, J. P. [9 ]
Van Lente, F. [10 ,11 ]
Gassman, J. [12 ]
Wang, X. [12 ]
Bakris, G. [13 ]
Appel, L. J. [1 ,2 ]
Contreras, G. [14 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Epidemiol, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Div Gen Internal Med, Baltimore, MD 21205 USA
[3] Ohio State Univ, Dept Nephrol, Columbus, OH 43210 USA
[4] Univ Michigan, Dept Med, Div Internal Med, Ann Arbor, MI 48109 USA
[5] Columbia Univ Coll Phys & Surg, Harlem Hosp Ctr, Dept Med, New York, NY 10032 USA
[6] Emory Univ, Dept Med, Div Renal, Atlanta, GA 30322 USA
[7] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA
[8] Vanderbilt Univ, Div Nephrol, Nashville, TN USA
[9] Univ Illinois, Nephrol Sect, Chicago, IL USA
[10] Cleveland Clin Fdn, Dept Clin Pathol, Cleveland, OH 44195 USA
[11] Cleveland Clin Fdn, Dept Hypertens & Nephrol, Cleveland, OH 44195 USA
[12] Cleveland Clin Fdn, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA
[13] Univ Chicago, Pritzker Sch Med, Dept Med, Chicago, IL 60637 USA
[14] Univ Miami, Miller Sch Med, Dept Med, Div Nephrol & Hypertens, Miami, FL 33152 USA
关键词
cardiovascular diseases; heart failure; hypertension; renal; kidney; natriuretic peptides;
D O I
10.1161/CIRCULATIONAHA.107.724187
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Higher levels of N-terminal prohormone brain-type natriuretic peptide (NT-proBNP) predict cardiovascular disease (CVD) in several disease states, but few data are available in patients with chronic kidney disease or in blacks. Methods and Results - The African American Study of Kidney Disease and Hypertension trial enrolled hypertensive blacks with a glomerular filtration rate of 20 to 65 mL . min(-1) . 1.73 m(-2) and no other identified cause of kidney disease. NT-proBNP was measured with a sandwich chemiluminescence immunoassay (coefficient of variation 2.9%) in 994 African American Study of Kidney Disease and Hypertension participants. NT-proBNP was categorized as undetectable, low, moderate, or high. Proteinuria was defined as 24-hour urinary protein - creatinine ratio >0.22. A total of 134 first CVD events (CVD death or hospitalization for coronary artery disease, heart failure, or stroke) occurred over a median of 4.3 years. Participants with high NT-proBNP were much more likely to have a CVD event than participants with undetectable NT-proBNP after adjustment (relative hazard 4.0 [95% confidence interval [CI] 2.1 to 7.6]). A doubling of NT-proBNP was associated with a relative hazard of 1.3 (95% CI 1.0 to 1.6) for coronary artery disease, 1.7 (95% CI 1.4 to 2.2) for heart failure, 1.1 (95% CI 0.9 to 1.4) for stroke, and 1.8 (95% CI 1.4 to 2.4) for CVD death. The association of NT-proBNP with CVD events was significantly stronger (P-interaction = 0.05) in participants with than in those without proteinuria. Higher NT-proBNP was not associated with renal disease progression. Conclusions - These results suggest that elevated NT-proBNP levels are associated with higher CVD risk among blacks with hypertensive kidney disease. This association may be stronger in individuals with significant proteinuria.
引用
收藏
页码:1685 / 1692
页数:8
相关论文
共 50 条
  • [21] Left ventricular geometric patterns in the African American study of kidney disease and hypertension (AASK) cohort
    de Backer, Tine L.
    Peterson, Gail
    Lansky, Alexandra J.
    Agodoa, Larry
    Appel, Larry
    Brittain, Karen
    Gassmann, Jennifer
    Kendrick, Cindy
    Lipkowitz, Michael
    Wright, Jackson T.
    Phillips, Robert A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 399A - 399A
  • [22] Usefulness of Age-Stratified N-Terminal Prohormone of Brain Natriuretic Peptide for Diagnosing Kawasaki Disease
    Lee, Sang Hoon
    Song, Eun Song
    Yoon, Somy
    Hong, Seunghee
    Cho, Hwa Jin
    Yang, Eun Mi
    Eom, Gwang Hyeon
    Kang, Gaeun
    Cho, Young Kuk
    DISEASE MARKERS, 2017, 2017
  • [23] N-Terminal Pro-Brain Natriuretic Peptide A Powerful Predictor of Mortality in Hypertension
    Paget, Vinciane
    Legedz, Liliana
    Gaudebout, Nathalie
    Girerd, Nicolas
    Bricca, Giampiero
    Milon, Hugues
    Vincent, Madeleine
    Lantelme, Pierre
    HYPERTENSION, 2011, 57 (04) : 702 - 709
  • [24] RECRUITMENT IN THE AFRICAN-AMERICAN STUDY OF KIDNEY-DISEASE AND HYPERTENSION (AASK) PILOT-STUDY
    WHELTON, P
    LEE, J
    KOPPLE, J
    FAULKNER, M
    CHARLESTON, J
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 570 - 570
  • [25] Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study
    Wright, JT
    Kusek, JW
    Toto, RD
    Lee, JY
    Agodoa, LY
    Kirk, KA
    Randall, OS
    Glassock, R
    CONTROLLED CLINICAL TRIALS, 1996, 17 (04): : S3 - S16
  • [26] Associations of Baseline and Longitudinal Serum Uromodulin With Kidney Failure and Mortality: Results From the African American Study of Kidney Disease and Hypertension (AASK) Trial
    Chen, Teresa K.
    Estrella, Michelle M.
    Appel, Lawrence J.
    Surapaneni, Aditya L.
    Kottgen, Anna
    Obeid, Wassim
    Parikh, Chirag R.
    Grams, Morgan E.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (01) : 71 - 78
  • [27] ARE THERE ANY ASSOCIATION BETWEEN DIASTOLIC AREA INDEX MEASURED BY ARTERIOGRAPH, RENAL FUNCTION AND N-TERMINAL PROHORMONE OF BRAIN NATRIURETIC PEPTIDE IN CHRONIC KIDNEY DISEASE?
    Sagi, Balazs
    Vas, Tibor
    Csepregi, Rita Klaudia
    Horvath-szalai, Zoltan
    Csiky, Botond
    Nagy, Judit
    Kovacs, Tibor Jozsef
    JOURNAL OF HYPERTENSION, 2024, 42
  • [28] N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure
    Bruch, Christian
    Reinecke, Holger
    Stypmann, Joerg
    Rothenburger, Markus
    Schmid, Christof
    Breithardt, Guenter
    Wichter, Thomas
    Gradaus, Rainer
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (09): : 1135 - 1141
  • [29] N-terminal pro-brain natriuretic peptide and cardiorenal outcome in patients with anaemia in chronic kidney disease
    Nishi, Hiroshi
    Nangaku, Masaomi
    Sofue, Tadashi
    Kagimura, Tatsuo
    Narita, Ichiei
    ESC HEART FAILURE, 2025, 12 (02): : 848 - 858
  • [30] Adding ambulatory blood pressure monitoring (ABPM) to the African American study of kidney disease and hypertension (AASK)
    Gassman, J
    Charleston, J
    Gabriel, A
    Hiremath, L
    Brittain, K
    Phillips, R
    Appel, L
    CONTROLLED CLINICAL TRIALS, 2003, 24 : 175S - 175S